HALO logo
halo search icon
Editas Medicine, Inc.

US$2.60

Price Change Indicator
0.14 (5.69%)
Editas Medicine, Inc.
EDIT · NAS

Editas Medicine, Inc.

Start Trading EDIT for Free

US$2.60

Price Arrow0.14 (5.69%)
20/05/2026 04:00:01 PM
All-CompaniesAll-ConsensusEngulfing BullishHALO AllHALO Balance SheetHALO Consensus Value
Consensus Score
Lock Icon/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

Editas Medicine, Inc. Overview

EDIT Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

HALO Model

Mqv

Very Weak

Garp

Very Weak

Mqv Small

Neutral

Valuation

Value

Lock Icon

Consensus

Lock Icon

Momentum

Price

Weak

Earnings

Strong

Growth

Earnings

Neutral

Dividends

Very Weak

Quality

Capital Efficiency

Very Weak

Balance Sheet

Strong

About EDIT

icon
icon

Telephone

1.617.401.9000

icon

Address

11 Hurley Street, Cambridge, MA 02141

Description

Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and David R. Liu on September 3, 2013 and is headquartered in Cambridge, MA.

EDIT Price Chart

Key Stats

Market Cap

US$240.85M

PE

0.00

EV/EBITDA

N/A

Dividends Overview

DIV Yield

0%

Franking

0%

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 1.47 - 4.54

Trade Value (12mth)

US$1,392,519.00

1 week

-6.11%

1 month

-25.45%

YTD

20%

1 year

64%

All time high

99.95

Key Fundamentals

EPS 3 yr Growth

-43.80%

EBITDA Margin

-232.10%

Operating Cashflow

-$165m

Free Cash Flow Return

-133.50%

ROIC

-129.30%

Interest Coverage

-15.20

Quick Ratio

3.50

Other Data

Shares Outstanding (Fully Diluted)

98m

HALO Sector

Healthcare

Next Company Report Date

25-Feb-27

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

USD

Short Sell (% of issue)

0.00

EDIT Announcements

Latest Announcements

DateAnnouncements
14 May 26
06 May 26
06 May 26
06 May 26
05 May 26

EDIT Fundamentals

Per Share Records

Historical data

Forecast data

USD2021202220232024202320242025202620272028
Per Share, Growth & Valuations
EPS (Basic)
 $locklocklocklock-2.02-2.88-1.8locklocklock
EPS (Fully Diluted)
 $locklocklocklock-2.02-2.88-1.8locklocklock
Growth
 %locklocklocklock37.2-42.837.4locklocklock
PE
 XlocklocklocklockN/AN/AN/Alocklocklock
EV/EBITDA
 XlocklocklocklockN/AN/AN/Alocklocklock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

0%

Franking Level

0%

DPSg

N/A

Quality Yield

lock

Falling Divs over next 2

lock

Want to learn more?Frequently asked questions.
What is the current share price of Editas Medicine, Inc. (EDIT:NAS)?
Halo FAQ
The current share price of Editas Medicine, Inc. (EDIT:NAS) is USD$2.60.
What is the 52-week high share price for Editas Medicine, Inc. (EDIT:NAS)?
Halo FAQ
The 52-week high share price for Editas Medicine, Inc. (EDIT:NAS) is USD$4.54.
What is the 52-week low share price for Editas Medicine, Inc. (EDIT:NAS)?
Halo FAQ
The 52-week low share price for Editas Medicine, Inc. (EDIT:NAS) is USD$1.47.
What is the dividend yield for Editas Medicine, Inc. (EDIT:NAS)?
Halo FAQ
Editas Medicine, Inc. (EDIT:NAS) does not pay a dividend.
What was Editas Medicine, Inc. (EDIT:NAS) last dividend payment?
Halo FAQ
Editas Medicine, Inc. (EDIT:NAS) does not pay a dividend.
What is the franking level for Editas Medicine, Inc. (EDIT:NAS)?
Halo FAQ
Editas Medicine, Inc. (EDIT:NAS) has a franking level of 0.00%.
In which sector is Editas Medicine, Inc. (EDIT:NAS) classified?
Halo FAQ
Editas Medicine, Inc. (EDIT:NAS) is classified in the Healthcare.

See beyond the curve.

One solution for research, investing and portfolio management.
Start FREE Trial